Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2021; 11(6): 125-131


A green analytical method for the determination of glucosamine using FTIR spectrophotometry

Lodoe Choezom, Ravandur Shivanna Chandan, Gurupadayya Bannimath.




Abstract
Cited by 0 Articles

Glucosamine is an amino sugar, naturally found in cartilage in between the joints. Glucosamine is prescribed for the treatment of osteoarthritis as it may either increase the content of cartilage or inhibit the enzyme responsible for the degradation of cartilage. As per the literature survey, glucosamine was analyzed using different methods, such as High performance liquid chromatography (HPLC) and UV Spectrophotometry, but none was carried out using Fourier Transform Infrared (FTIR) Spectroscopy. Therefore, the present work aims to carry out a green method for the analysis of glucosamine in marketed tablets using FTIR. The qualitative and quantitative analysis of glucosamine was carried out using the KBr pellet method in the mid-infrared region. The method involves the direct measurement of absorbance of the amine group peak at 3309 and 3356 cm−1. The proposed method is validated according to the ICH guidelines (The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use). Excellent linearity was obtained in the concentration range of 2–7%w/w (R² = 0.9902). The percentage purity of the glucosamine tablet was found to be 99.629%. The results obtained indicate that the proposed method used to analyze glucosamine is precise, accurate, and reproducible. Thus, a simple, rapid, economical, and environmentfriendly method was developed and validated for the analysis of glucosamine in marketed tablets and it can be used for the quality control of routine analysis of this drug.

Key words: Glucosamine, FTIR, Green method, Osteoarthritis, Validation






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.